From Surf Wiki (app.surf) — the open knowledge base
2C-G-5
| Field | Value | |||
|---|---|---|---|---|
| image | 2C-G-5.svg | |||
| image_class | skin-invert-image | |||
| width | 250px | |||
| image2 | 2C-G-5 ball-and-stick structure.png | |||
| image_class2 | bg-transparent | |||
| width2 | 215px | |||
| routes_of_administration | Oral | |||
| class | Serotonergic psychedelic; Hallucinogen | |||
| ATC_prefix | None | |||
| onset | 1–2 hours | |||
| duration_of_action | 32–48 hours | |||
| CAS_number | 207740-20-3 | |||
| PubChem | 44349968 | |||
| ChemSpiderID | 23206405 | |||
| UNII | BW3Q32DFC9 | |||
| ChEMBL | 123976 | |||
| synonyms | 3,4-Norbornyl-2,5-DMPEA; 3,4-Norbornyl-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-3,4-norbornylphenethylamine; 3,6-Dimethoxy-4-(2-aminoethyl)benzonorbornane | |||
| IUPAC_name | 2-(3,6-dimethoxy-4-tricyclo[6.2.1.02,7]undeca-2,4,6-trienyl)ethanamine | |||
| C | 15 | H=21 | N=1 | O=2 |
| SMILES | COC1=C2C3CCC(C3)C2=C(C(=C1)CCN)OC | |||
| StdInChI | 1S/C15H21NO2/c1-17-12-8-11(5-6-16)15(18-2)14-10-4-3-9(7-10)13(12)14/h8-10H,3-7,16H2,1-2H3 | |||
| StdInChIKey | ASPWVWSIJQTXDB-UHFFFAOYSA-N |
| Drugs.com =
| elimination_half-life =
2C-G-5, also known as 3,4-norbornyl-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families. It is one of several homologues of 2C-G (3,4-dimethyl-2,5-dimethoxyphenethylamine). The drug is taken orally. 2C-G-5 was encountered online as a novel designer drug in 2025.
Use and effects
In his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists 2C-G-5's dose as 10 to 16mg orally and its duration as 32 to 48hours. The drug's onset is 1 to 2hours and its time to peak is 2.5 to 3hours. 2C-G-5 is reported to produce psychedelic effects including visuals, clear and cosmic thinking, and 2C-B-like enhanced eroticism, among others. It is among the most potent of the 2C psychedelics. However, its duration is described as too long, interfering with sleep and resulting in subsequent-day consequences like tiredness and sleepiness. 2C-G-5 was also the longest-lasting drug included in PiHKAL based on its specified duration.
Interactions
Pharmacology
Data on the pharmacology and toxicology of 2C-G-5 are unavailable.
Chemistry
Synthesis
The chemical synthesis of 2C-G-5 has been described.
Analogues
Analogues of 2C-G-5 include other compounds of the 2C-G and Ganesha series, among others. Examples include 2C-G (2C-G-0), 2C-G-3, 2C-G-4, 2C-G-N, and G-5.
History
2C-G-5 was first described in the literature by Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved). It was encountered online as a novel designer drug in 2025.
Society and culture
Legal status
Canada
2C-G-5 is a controlled substance in Canada under phenethylamine blanket-ban language.
United States
2C-G-5 is not an explicitly controlled substance in the United States. However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.
References
References
- (2013). "Phenethylamine: von der Struktur zur Funktion". Nachtschatten-Verlag.
- "2C-G-5".
- (1994). "Structure-activity relationships of the classic hallucinogens and their analogs". NIDA Research Monograph.
- (2003). "Hallucinogens: A Forensic Drug Handbook". Elsevier Science.
- (2011). "[[The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds]]". [[Transform Press]].
- "2C-G-5".
- "Controlled Drugs and Substances Act".
- (January 2026). "Orange Book: List of Controlled Substances and Regulated Chemicals (January 2026)". U.S. [[Department of Justice]]: [[Drug Enforcement Administration]] (DEA): Diversion Control Division.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about 2C-G-5 — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report